Guidant/CPI Announces Market Release of VENTAK MINI Defibrillation System in U.S.INDIANAPOLIS--(HealthWire)--Dec. 26, 1995--Guidant Corporation (NYSE NYSE See: New York Stock Exchange :GDT) and CPI, a worldwide leader in implantable defibrillation Defibrillation Definition Defibrillation is a process in which an electronic device sends an electric shock to the heart to stop an extremely rapid, irregular heartbeat, and restore the normal heart rhythm. systems, today announced the market release of the VENTAK(R) MINI(TM) family of AICD AICD activation-induced cell death; automatic implantable cardioverter-defibrillator. (TM) Automatic Implantable Cardioverter Defibrillator devices in the United States. This new defibrillator family offers the smallest and most advanced devices available and sets the new standard for treating patients with life-threatening rapid heart arrhythmias. The VENTAK MINI pulse generator is 68 cc in size and weighs 125 grams, making it 30 percent smaller than VENTAK PRx III, CPI's most recently market-released predecessor and 15 percent smaller than the Medtronic Jewel device. The VENTAK MINI device is designed and labeled for implantation in the patient's shoulder (pectoral pectoral /pec·to·ral/ (pek´ter-il) thoracic. pec·to·ral adj. 1. Relating to or situated in the breast or chest. 2. ) area, which can greatly reduce the time and costs associated with the implantation procedure and enhance patient comfort. The VENTAK MINI device includes CPI's proven biphasic bi·pha·sic adj. Having two distinct phases: a biphasic waveform; a biphasic response to a stimulus. waveform, more than 5 minutes of diagnostic-quality stored electrograms, and comprehensive therapy and diagnostics, making it the world's smallest full-featured implantable defibrillator. The VENTAK MINI product family is the first of a new generation of advanced tiered therapy cardiac rhythm management Cardiac rhythm management is a field of treatment in cardiology. The purpose is managing cardiac rhythm disorders. Usually it involves artificial pacemakers and/or implantable cardioverter-defibrillator therapy as well as antiarrhythmia drugs. systems that provide antitachycardia pacing (ATP ATP: see adenosine triphosphate. ATP in full adenosine triphosphate Organic compound, substrate in many enzyme-catalyzed reactions (see catalysis) in the cells of animals, plants, and microorganisms. ), cardioversion Cardioversion Definition Cardioversion refers to the process of restoring the heart's normal rhythm by applying a controlled electric shock to the exterior of the chest. , defibrillation and bradycardia bradycardia: see arrhythmia. pacing. The family also includes several extended life models that offer the physician the greatest device longevity (approximately 7 years depending upon therapy use) in the smallest product available. The first implants of the VENTAK MINI occurred in Europe and Canada in late August and the product was market released there on December 1. To date, more than 250 devices have been implanted in 20 countries worldwide. "The VENTAK MINI family is the most sophisticated family of products available to treat rapid heart rhythms," according to Jay Graf, president of CPI and a vice president of Guidant Corporation. "Combined with CPI's ENDOTAK(R) DSP, our fourth generation defibrillation lead, VENTAK/ENDOTAK system energy requirements for defibrillation and our single lead implant success rate set the industry standard. While current medical literature reports on the problems of lead fractures and dislodgments of competitive defibrillation leads, CPI's ENDOTAK leads continue to demonstrate superior design, and proven reliability and performance. "In addition, many of our customers consistently comment on the superior ease-of-use and visualization of the system's diagnostic capabilities through the Model 2950 Programmer-Recorder-Monitor (PRM) that is used for device programming at implant and patient follow-up," Graf added. "The PRM, combined with the device's diagnostic features, gives the user the most sophisticated patient management capability available today." A leader in the medical device industry, Guidant Corporation provides innovative, cost-effective products and services to the global cardiology and minimally invasive surgery minimally invasive surgery Laparoscopic surgery, see there. See Laparoscopic cholecystectomy. marketplaces. Part of Guidant's Cardiac Rhythm Management group, CPI, headquartered in St. Paul, Minnesota, manufactures and markets heart pacemaker systems, AICD implantable cardioverter defibrillators, defibrillation and pacing lead systems, device programmers and related products. CONTACT: CPI Carol A. Lindahl, 612/582-4461 or Guidant Robert E. Allen, 317/971-2031 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion